Different Spinal Needles Sizes and Dural Puncture Epidural For Labor Analgesia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03389945 |
|
Recruitment Status :
Completed
First Posted : January 4, 2018
Last Update Posted : June 4, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The rationale behind the dural puncture epidural (DPE) technique lies in the fact that a dural perforation with a spinal needle purportedly creates a conduit for accelerated translocation of local anesthetics from the epidural to the subarachnoid space. When compared with conventional epidural block, it provides improved sacral block and onset of analgesia.
Despite the benefits associated, the supportive literature remains scarce. No trial has determined if similar results could be obtained with a smaller needle.
In this trial, DPE using 25- and 27-gauge (G) spinal needles are compared. The main outcome will be the time required to obtain a pain score ≤ 1 using a 0-10 numeric rating scale (NRS). The hypothesis is that that both needle sizes will result in similar onset times and therefore designing the current study as an equivalence trial.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Labor Pain Epidural Analgesia | Procedure: 25G Dural Puncture Epidural Block Procedure: 27G Dural Puncture Epidural Block | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 140 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Primary Purpose: | Supportive Care |
| Official Title: | Dural Puncture Epidural For Early Labor Analgesia: A Randomized Comparison Between 27- and 25-Gauge Pencil Point Spinal Needles. |
| Actual Study Start Date : | January 13, 2018 |
| Actual Primary Completion Date : | March 12, 2019 |
| Actual Study Completion Date : | March 19, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: 25G Dural Puncture Epidural Block
Patients will receive a dural puncture epidural block with a 25 gauge spinal needle.
|
Procedure: 25G Dural Puncture Epidural Block
Dural puncture epidural analgesia using a 25G pencil point spinal needle at a lumbar interspace. Then 20ml of bupivacaine 0.125% + fentanyl 2ug/ml will be injected in the epidural space. |
|
Experimental: 27G Dural Puncture Epidural Block
Patients will receive a dural puncture epidural block with a 27 gauge spinal needle.
|
Procedure: 27G Dural Puncture Epidural Block
Dural puncture epidural analgesia using a 27G pencil point spinal needle at a lumbar interspace. Then 20ml of bupivacaine 0.125% + fentanyl 2ug/ml will be injected in the epidural space. |
- Time to pain ≤ 1 on NRS (0-10) [ Time Frame: Up to 30 minutes after local anesthetic injection ]Time elapsed between the end of local anesthetic injection and achievement of pain ≤ 1 on the NRS (measured every 2 minutes)
- Gestational age [ Time Frame: 42 weeks ]Gestational age at the time of recruitment
- Obstetric history [ Time Frame: At the time of recruitment ]Number of previous pregnancies and deliveries
- Type of labor [ Time Frame: At the time of delivery ]Spontaneous versus induced labor
- Oxytocin dose [ Time Frame: At the time of DPE ]Oxytocin infusion/dose at time of DPE
- Cervical dilation [ Time Frame: At the time of DPE ]Cervical dilation at the time of DPE
- State of membrane [ Time Frame: At the time of DPE ]Intact versus ruptured membrane at the time of DPE
- Pre-DPE level of pain [ Time Frame: Immediate before DPE ]Evaluated with a NRS from 0 to 10
- Amount of IV fluids [ Time Frame: 24 hours ]Total intravenous fluid received during labor (from admission to the obstetric suite up to delivery)
- Intervertebral level of puncture [ Time Frame: At the time of DPE ]Lumbar interspace where DPE was successfully performed
- Number of DPE attempts [ Time Frame: 1 hour ]Number of attempts for successful DPE
- Incidence of accidental dural puncture [ Time Frame: 1 hour ]Incidence of accidental dural puncture with the epidural Tuohy needle
- Performance time [ Time Frame: 1 hour ]Temporal interval between skin disinfection and epidural catheter fixation to the skin
- Sensory block height [ Time Frame: Up to 30 minutes after local anesthetic injection ]Sensory block height at 30 minutes after local anesthetic injection
- Bilateral S2 sacral root block [ Time Frame: Up to 30 minutes after local anesthetic injection ]Measured every 2 minutes after local anesthetic injection
- Presence of motor block [ Time Frame: Up to 30 minutes after local anesthetic injection ]Evaluated using a modified Bromage score
- Number of epidural top-ups during labor [ Time Frame: After DPE up to delivery ]Number of extra doses of local anesthetic given after DPE up to delivery
- Type of delivery [ Time Frame: Delivery ]Incidence of Cesarean section, normal delivery, and instrumented delivery
- Incidence of epidural catheter adjustment or replacement [ Time Frame: After DPE up to delivery ]Necessity of adjustment or replacement of the epidural catheter
- DPE side effects [ Time Frame: After DPE up to delivery ]Incidence of nausea, pruritus, hypotension
- Fetal-Uterine assessment [ Time Frame: Before and up to 1 hour after DPE ]Frequency of contractions, uterine tonus, fetal heart rate tracing
- Tocolysis requirement [ Time Frame: Up to 1 hour after DPE ]Necessity to administer a tocolytic agent after DPE
- Apgar scores [ Time Frame: At 1 and 5 minutes after delivery ]Assessment of newborn condition
- DPE complications [ Time Frame: After DPE up to 7 days postpartum ]Incidence of post dural puncture headache, back pain, paresthesia and motor deficit
- Epidural blood patch incidence [ Time Frame: Up to 1 week of followup ]Necessity of performing of a blood patch to relieve post dural puncture headache symptoms
- Demographic data [ Time Frame: At the time of recruitment ]Age, height, weight, BMI
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- healthy pregnant woman
- singleton and vertex presentation
- 37-42 weeks of gestational age
- active labor with cervical dilation < 5cm
- body mass index between 20 and 35 kg/m2
- desired labor epidural analgesia
Exclusion Criteria:
- adults who are unable to give their own consent
- presence of any pregnancy-related disease (e.g., gestational hypertension, preeclampsia, gestational diabetes)
- known fetal anomalies
- increased risk of cesarean delivery (e.g., previous uterine rupture, previous cesarean delivery)
- coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or partial prothrombin time ≥ 50)
- renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100)
- hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100)
- allergy to LA
- prior sacral or lumbar spine surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03389945
| Chile | |
| Hospital Clínico Universidad de Chile | |
| Santiago, Metropolitana, Chile | |
| Hospital La Florida | |
| Santiago, Región Metropolitana, Chile | |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Felipe Contreras Godoy, Clinical Instructor, Department of Anesthesia, University of Chile |
| ClinicalTrials.gov Identifier: | NCT03389945 |
| Other Study ID Numbers: |
922/17 |
| First Posted: | January 4, 2018 Key Record Dates |
| Last Update Posted: | June 4, 2020 |
| Last Verified: | June 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Labor analgesia Dural puncture epidural Postdural puncture headache Neuraxial analgesia |
|
Agnosia Labor Pain Perceptual Disorders Neurobehavioral Manifestations |
Neurologic Manifestations Nervous System Diseases Pain |

